Copy
The future of medicine and health
30 Under 30 Europe Science & Healthcare: How a 29-year-old went from a shallot farm to the c-suite
Twenty-nine-year-old Yann Fleureau’s first job was as a seasonal worker on a shallot farm when he was 16. His latest gig is more high tech. Since the French entrepreneur founded Cardiologs in 2014, he’s raised $10 million to realize his vision of helping doctors who aren’t cardiologists better analyze EKG exams.

His company’s medical device uses deep learning to help doctors recognize rhythmic abnormalities, and it received commercial regulatory approval from the EU in 2016 and clearance from the U.S. Food & Drug Administration in 2017.

But Fleureau is just one of the honorees who made the cut for this year’s 30 Under 30 Europe Science and Healthcare list.  Read more from Michela Tindera, Ellie Kincaid and Robin Andrews on Forbes
MAKING THE ROUNDS
Blue Cross Blue Shield is involved in expanding food delivery to 40 zip codes considered "food deserts" in Chicago and Dallas through a new service as health insurers push further into addressing social determinants of health.

As the 116th Congress opens with hearings on drug pricing, old issues are again resurfacing and new outrage is being expressed surrounding the role of the NIH in drug discovery.

Gossamer Bio CEO Sheila Gujrathi launched what she calls her dream company early last year. Thirteen months later it raised $276 million in its initial public offering. Here’s what she had to say about the journey so far. 
NEWS YOU CAN USE

There is an age-old belief that if you are drinking alcohol, you should always drink beer before wine to avoid a more unpleasant hangover. But is there any truth to it?

A new study in the American Journal of Clinical Nutrition sought to finally find that out. Participants were split randomly into three study groups to drink beer and wine in varying succession. Then, they were asked to report how drunk they felt and to rate their hangover the next day.  Read more.
Did someone forward you this newsletter? Subscribe here.
Get more from
Innovation Rx
Follow us on
Twitter
Read more from Forbes 
Copyright © 2019 Forbes, All rights reserved.